| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.5 |